Fibralign Corporation

medical devices

About

Fibralign Corporation is a Stanford University spin-out produces advanced therapeutic biomedical devices, utilizing its powerful patented Nanoweave® technology. Launched first product - BioBridge® Collagen Matrix for the treatment of secondary lymphedema, a global chronic and disfiguring disease that currently has no cure. BioBridge has received an initial 510(k) clearance, CE mark and KFDA approval and now being used by leading surgeons in 18 countries.  MedTech Innovator Award - Overall Winner out of over 800 MedTech startups in this prestigious annual competition  StartX Med - Stanford start-up community for healthcare companies (Acceptance rate < 8%) https://www.linkedin.com/company/startx-/  Selected as a UCSF Rosenman Institute Innovator  Founding cohort of JLABs @ SSF

Technologies

Gmail Google Apps Google Cloud Hosting WordPress.org Mobile Friendly Google Font API Google Maps Google Tag Manager Nginx Quantcast Remote IoT AI

Keywords

regenerative medicine scaffolding technology lymphedema pad nerve repair medical device drug delivery iso 13485 collagen scaffolding breast cancer wound care soft tissue alzheimers disease 510 ce mark kfda medical equipment manufacturing biotechnology clinical studies nanoweave technology regenerative scaffolds clinical research biomaterials collagen-based regenerative therapy fda 510(k) clearance nanostructured tissue scaffolds medical equipment and supplies manufacturing microenvironment support preclinical studies nanofibrillar scaffolding

Location

32930 Alvarado Niles Rd, Union City, California, United States, 94587

Related Companies

Companies in the same industry